Skip to main content
. Author manuscript; available in PMC: 2010 Nov 22.
Published in final edited form as: Am J Obstet Gynecol. 2010 Jun 12;203(2):138.e1–138.e8. doi: 10.1016/j.ajog.2010.05.006

TABLE 2.

Distribution of children with small head circumference growth in strata defined by pregnancy characteristics and exposures during pregnancy

Exposures and characteristics Head circumference Z-scorea n
<−2 ≥−2 to <−1
Smoking prepregnancyb Yes 8 23 359
No 10 21 1012
Smoking during pregnancyb Yes 8 25 205
No 10 21 1166
Years since last pregnancy <1 7 23 163
1–2 8 17 235
≥2 11 23 417
Conception assistance Yes 7 17 271
No 10 23 1096
Vaginal bleeding
 ≤12 wkb Yes 8 21 522
No 10 23 844
 >12 wkb Yes 7 21 392
No 11 22 974
Illnesses this pregnancy
 Feverb Yes 10 25 83
No 10 22 1282
 Vaginal/cervical infection Yes 7 24 187
No 10 22 1179
 UTIb Yes 10 25 219
No 10 21 1147
Medications
 Anyb Yes 10 22 159
No 6 23 1206
 Aspirinb Yes 8 26 80
No 10 22 1280
 NSAIDb Yes 4 27 99
No 10 21 1260
 Acetaminophenb Yes 11 21 697
No 8 22 662
 Antibioticb Yes 10 24 430
No 9 21 930
Maximum no. of infants 138 317 1445

These are row percents.

NSAID, nonsteroidal antiinflammatory drug; UTI, urinary tract infection.

a

External standard is Oxford, United Kingdom, dataset;11

b

infants may be in >1 category.

McElrath. Factors associated with small head circumference at birth among ELGAN. Am J Obstet Gynecol 2010.